Drug Discovery & Development | Prostate Cancer Trial Launched for Xofigo Monthly Prescribing Reference Bayer HealthCare announced that it has begun enrolling patients into a Phase 3 trial studying Xofigo (radium Ra 223 dichloride) injection in combination with Zytiga (abiraterone acetate; Janssen) and prednisone/prednisolone for the treatment of ... Bayer Begins To Enroll Patients In Late-stage Trial With Radium-223 Dichloride Bayer Launches Phase 3 Prostate Cancer Trial |
